{
      "brief_title": [
            "safety",
            "efficacy",
            "aliskiren",
            "add",
            "standardize",
            "losartan",
            "optimal",
            "antihypertensive",
            "therapy",
            "patient",
            "hypertension",
            "type",
            "2",
            "diabetes",
            "proteinuria"
      ],
      "brief_summary": [
            "study",
            "efficacy",
            "safety",
            "aliskiren",
            "add",
            "losartan",
            "optimal",
            "antihypertensive",
            "therapy",
            "patient",
            "hypertension",
            "type",
            "2",
            "diabetes",
            "kidney",
            "disorder",
            "monitor",
            "improvement",
            "condition"
      ],
      "condition": [
            "nephropathy"
      ],
      "intervention_type": [
            "Drug"
      ],
      "intervention_name": [
            "aliskiren"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "hypertension",
            "elevate",
            "urinary",
            "protein",
            "level",
            "confirm",
            "type",
            "2",
            "diabetes",
            "exclusion",
            "criterion",
            "certain",
            "disease",
            "uncontrolled",
            "diabetes",
            "type",
            "1",
            "diabetes"
      ],
      "gender": "All",
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [
            "80",
            "year"
      ],
      "healthy_volunteers": "No",
      "keyword": [
            "losartan"
      ],
      "mesh_term": [
            "disease",
            "nephropathy",
            "agent"
      ],
      "id": "NCT00097955"
}